Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 11:48 PM
Study NCT ID:
NCT07193394
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-25
First Post:
2025-09-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Sponsor:
Institut Curie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-08
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-12
First Submit QC Date:
None
Study First Post Date:
2025-09-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-18
Last Update Post Date:
2025-09-25
Last Update Post Date Type:
ESTIMATED